Selective neuronal nitric oxide synthase inhibitors

Frontiers in Medicinal Chemistry

Volumn 4, Issue 1, 2009, Pages 842-882

  Ji, Haitao ^a   Erdal, Erik P ^a   Litzinger, Elizabeth A ^a   Seo, Jiwon ^a   Zhu, Yaoqiu ^a   Xue, Fengtian ^a   Fang, Jianguo ^a   Huang, Jinwen ^a   Silverman, Richard B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70749108558     PISSN: 15672042     EISSN: 18755763     Source Type: Book Series    
DOI: None     Document Type: Review

References (238)

1. Silverman, R.B. The Organic Chemistry of Enzyme-Catalyzed Reactions; Academic Press, San Diego., 2002, pp. 570-584.
2. Segel, I.H. Enzyme Kinetics, John Wiley & Sons, New York, 1975, pp. 106
3. Burlingham, B.T.; Widlanski T.S. An Intuitive Look at the Relationship of Ki and IC50: A More General Use for the Dixon Plot.J. Chem. Educ., 2003, 80, 214-218.
4. Kerwin, J.F. Jr.; Lancaster, J.R., Jr. Nitric Oxide; a New Paradigm for Second Messengers. Med. Res. Rev., 1994, 14, 23-74
5. Stuehr, D.J. Enzymes of the L-Arginine to Nitric Oxide Pathway. J. Nutr., 2004, 134(10 Suppl.), 2748S-2751S.
6. Kerwin, J.F. Jr.; Heller, M. The Arginine-Nitric Oxide Pathway: A Target for New Drugs.J. Med. Chem., 1995, 38, 4342-4362.
7. Stuehr, D.J.; Griffith, O.W. Mammalian Nitric Oxide Synthases. Adv. Enzymol. Relat. Areas Mol. Biol., 1992, 65, 287-346.
8. Schmidt, H.H. H.W.; Walter, U. NO at Work. Cell, 1994, 78, 919-925.
9. Forstermann, U.; Pollock, J.S.; Schmidt, H.H. H.W.; Heller, M.; Murad, F. Calmodulin-Dependent Endothelium-Derived Relaxing Factor / Nitric Oxide Synthase Activity is Present in the Particulate and Cytosolic Fractions of Bovine Aortic Endothelial Cells. Prot. Natl. Acad. Sci. USA, 1991, 88, 1788-1792.
10. MacMicking, J.; Xie, Q.W.; Nathan, C. Nitric Oxide and Macrophage Function. Annu. Rev. Immunol., 1997, 15, 323-350.
11. Drummond, G.I. In Cyclic Nucleotides in the Nervous System; Raven Press: New York; 1984, pp. 40-125
12. Garthwaite, J. In Nitric Oxide from L-Arginine: A Bioregulatory System; Moncada, S.; Higgs, E.A., Eds.; Elsevier: Amsterdam, 1990; pp. 115-137.
13. Merighi, A.; Aimar, P.; Lossi, L.; Pasti, L.; Carmignoto, G. Neuromodulatory Effects of Nitric Oxide in Pain Perception. Oxid. Stress Dis., 2000, 5, 17-53
14. Forman, L.J.; Tringo, L.; Sun, M. Cocaine and Inhibition of Nitric Oxide Synthesis Produce Opioid-Mediated Antinociception. Brain Res. Bull., 1997, 44, 125-129.
15. Lev-Ram, V.; Wong, S.T.; Storm, D.R.; Tsien, R.Y. A New Form of Cerebellar Long-Term Potentiation is Postsynaptic and Depends on Nitric Oxide but not cAMP. Proc. Natl. Acad. Sci. USA, 2002, 99, 8389-8393
16. Grassi, S.; Pettorossi, V.E. Role of Nitric Oxide in Long-Term Potentiation of the Rat Medial Vestibular Nuclei. Neuroscience, 2000, 101, 157-164.
17. Furchgott, R.F.; Zawadzki, J.V. The Obligatory Role of Endothelial Cells in the Relaxation of Arterial Smooth Muscle by Acetylcholine. Nature, 1980, 288, 373-376
18. Palmer, R.M. J.; Ferrige, A.G.; Moncada, S. Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxing Factor. Nature, 1987, 327, 524-526.
19. Moncada, S.; Palmer, R.M. J.; Higgs, E.A. Biosynthesis of Nitric Oxide from L-Arginine. A Pathway for the Regulation of Cell Function and Communication. Biochem. Pharmacol., 1989, 38, 1709-1715.
20. Lyons, C.R. The Role of Nitric Oxide in Inflammation. Adv. Immunol., 1995, 60, 323-371
21. Hibbs, J.B. Jr.; Vavrin, Z.; Taintor, R.R. L-Arginine is Required for Expression of the Activated Macrophage Effector Mechanism Causing Selective Metabolic Inhibition in Target Cells. J. Immunol., 1987, 138, 550-565
22. Hibbs, J.B. Jr.; Taintor, R.R.; Vavrin, Z.; Granger, D.L.; Drapier, J.-C.; Amber, I.J.; Lancaster, J.R. Jr. In Nitric Oxide from L-Arginine: A Bioregulatory System; Moncada, S.; Higgs, E.A., Eds.; Elsevier: Amsterdam, 1990; pp. 189-223.
23. Russwurm, M.; Koesling, D. Guanylyl Cyclase: NO Hits Its Target. Biochem. Soc. Symp., 2004, 71, 51-63
24. Ignarro, L.J. Nitric Oxide. A Novel Signal Transduction Mechanism for Transcellular Communication. Hypertension, 1990, 16, 477-483.
25. Emerit, J.; Edeas, M.; Bricaire, F. Neurodegenerative Diseases and Oxidative Stress. Biomed. Pharmacother., 2004, 58, 39-46
26. Vallance, P.; Leiper, J. Blocking NO Synthesis: How, Where and Why? Nature Rev. Drug Disc., 2002, 1, 939-950
27. Grunewald, T.; Beal, M.F. NOS Knockouts and Neuroprotection. Nat. Med., 1999, 5, 1354-1355
28. Dawson, V.L.; Dawson, T.M. Nitric Oxide in Neurodegeneration. Prog. Brain Res., 1998, 118, 215-229
29. Schulz, J.B.; Matthews, R.T.; Klockgether, T.; Dichgans, J.; Flint, B.M. The Role of Mitochondrial Dysfunction and Neuronal Nitric Oxide in Animal Models of Neurodegenerative Diseases. Mol. Cell. Biochem., 1997, 174, 193-197.
30. Eliasson, M.J.; Huang, Z.; Ferrante, R.J.; Sasamata, M.; Molliver, M.E.; Snyder, S.H.; Moskowitz, M.A. Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation in Ischemic Stroke Linked to Neural Damage. J. Neurosci., 1999, 19, 5910-5918
31. Huang, Z.; Effects of Cerebral Ischaemia in Mice Deficient in Neuronal Nitric Oxide Synthase. Science, 1994, 265, 1883-1885.
32. Ashina, M. Nitric Oxide Synthase Inhibitors for the Treatment of Chronic Tension-Type Headache. Expert Opin. Pharmacother., 2002, 3, 395-399
33. Sarchielli, P.; Alberti, A.; Floridi, A.; Gallai, V. LArginine/ Nitric Oxide Pathway in Chronic Tension-Type Headache: Relation with Serotonin Content and Secretion and Glutamate Content. J. Neurol. Sci., 2002, 198, 9-15.
34. Gatto, E.M.; Riobo, N.A.; Carreras, M.C.; Poderoso, J.J. Nitric Oxide Overproduction and Oxidative Stress in Human Idiopathic Parkinson's Disease. Oxid. Stress Dis., 2000, 5, 291-311.
35. Togo T.; Katsuse O.; Iseki E. Nitric Oxide Pathways in Alzheimer's Disease and Other Neurodegenerative Dementias. Neurol. Res., 2004, 26, 563-566
36. Dorheim, M.-A.; Tracey, W.R.; Pollock, J.S.; Grammas, P. Nitric Oxide Synthase Activity is Elevated in Brain Microvessels in Alzheimer's Disease. Biochem. Biophys. Res. Commun., 1994, 205, 659-665.
37. DiGirolamo, G.; Farina, M.; Riberio, M.L.; Ogando, D.; Aisemberg, J.; de los Santos, A.R.; Marti, M.L.; Franchi, A.M. Effects of Cyclooxygenase Inhibitor Pretreatment on Nitric Oxide Production, nNOS and iNOS Expression in Rat Cerebellum. Br.J. Pharmacol., 2003, 139, 1164-1170
38. Perez-Severiano, F.; Escalante, B.; Vergara, P.; Rios, C.; Segovia, J. Age-Dependent Changes in Nitric Oxide Synthase Activity and Protein Expression in Striata of Mice Transgenic for the Huntington's Disease Mutation. Brain Res., 2002, 951, 36-42.
39. Boughton-Smith, N.K.; Tinker, A.C. Inhibitors of Nitric Oxide Synthase in Inflammatory Arthritis. Drugs, 1998, 1, 321-333
40. Bingham, C.O. III. The Pathogenesis of Rheumatoid Arthritis: Pivotal Cytokines Involved in Bone Degradation and Inflammation. J. Rheumatol. Suppl., 2002, 65, 3-9.
41. Kankuri, E.; Vaali, K.; Knowles, R.G.; Lahde, M.; Korpela, R.; Vapaatalo, H.; Moilanen, E. Suppression of Acute Experimental Colitis by a Highly Selective Inducible Nitric-Oxide Synthase Inhibitor, N-[3-(Aminomethyl)benzyl]acetamidine. J. Pharmacol. Exp. Ther., 2001, 298, 1128-1132
42. Hokari, R.; Kato, S.; Matsuzaki, K.; Kuroki, M.; Iwai, A.; Kawaguchi, A.; Nagao, S.; Miyahara, T.; Itoh, K.; Sekizuka, E.; Nagata, H.; Ishii, H.; Miura, S. Reduced Sensitivity of Inducible Nitric Oxide Synthase-Deficient Mice to Chronic Colitis. Free Rad. Boil. Med., 2001, 31, 153-163
43. Cho, C.H. Current Roles of Nitric Oxide in Gastrointestinal Disorders. J. Physil. Paris, 2001, 95, 253-256.
44. Tinker, A.C.; Beaton, H.G.; Boughton-Smith, N.; Cook, T.R.; Cooper, S.L.; Fraser-Rae, L.; Hallam, K.; Hamley, P.; McInally, T.; Nicholls, D.J.; Pimm, A.D.; Wallace, A.V. 1,2-Dihydro-4-quinazolinamines: Potent, Highly Selective Inhibitors of Inducible Nitric Oxide Synthase Which Show Antiinflammatory Activity in vivo. J. Med. Chem., 2003, 46, 913-916.
45. Alcaraz, M.J.; Guillen, M.I. Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task. Curr. Pharm. Des., 2002, 8, 215-231
46. Hobbs, A.J.; Higgs, A.; Moncada, S. Inhibition of Nitric Oxide Syntasse as a Potential Therapeutic Target. Annu. Rev. Pharmacol. Toxcol., 1999, 39, 191-220.
47. Knowles, R.G.; Moncada, S. Nitric Oxide Synthases in Mammals. Biochem. J., 1994, 198, 249-258.
48. Crane, B.R.; Arvai, A.S.; Gachhui, R.; Wu, C.; Ghosh, D.K.; Getzoff, E.D.; Stuehr, D.J.; Tainer, J.A. The Structure of Nitric Oxide Synthase Oxygenase Domain and Inhibitor Complexes. Science, 1997, 278, 425-431.
49. Crane, B.R.; Arvai, A.S.; Ghosh, S.; Getzoff, E.D.; Stuehr, D.J.; Tainer, J.A. Structures of the Nα-Hydroxy-L-arginine Complex of Inducible Nitric Oxide Synthase Oxygenase Dimer with Active and Inactive Pterins. Biochemistry, 2000, 39, 4608-4621.
50. Crane, B.R.; Arvai, A.S.; Ghosh, D.K.; Wu, C.; Getzoff, E.D.; Stuehr, D.J.; Tainer, J.A. Structure of Nitric Oxide Synthase Oxygenase Dimer with Pterin and Substrate. Science, 1998, 279, 2121-2126.
51. Fischmann, T.O.; Hruza, A.; Niu, X.D.; Fossetta, J.D.; Lunn, C.A.; Dolphin, E.; Prongay, A.J.; Reichert, P.; Lundell, D.J.; Narula, S.K.; Weber, P. Structural Characterization of Nitric Oxide Synthase Isoforms Reveals Striking Active-Site Conservation. Nat. Struct. Biol., 1999, 6, 233-242.
52. Li, H.; Raman, C.S.; Glaser, C.B.; Blasko, E.; Young, T.A.; Parkinson, J.F.; Whitlow, M.; Poulos, T.L. Crystal Structures of Zinc-Free and-Bound Heme Domain of Human Inducible Nitric-Oxide Synthase.J. Biol. Chem., 1999, 274, 21276-21284.
53. Raman, C.S.; Li, H.; Martásek, P.; Král, V.; Masters, B.S. S.; Poulos, T.L. Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase: A Paradigm for Pterin Function Involving a Novel Metal Center. Cell, 1998, 95, 939-950.
54. Li, H.; Shimizu, H.; Flinspach, M.; Jamal, J.; Yang, W.; Xian, M.; Cai, T.; Wen, E.Z.; Jia, Q.; Wang, P.G.; Poulos, T.L. The Novel Binding Mode of N-Alkyl-N'-hydroxyguanidine to Neuronal Nitric Oxide Synthase Provides Mechanistic Insights into NO Biosynthesis. Biochemistry, 2002, 41, 13868-13875
55. Flinspach, M.; Li, H.; Jamal, J.; Yang, W.; Huang, H.; Hah, J.-M.; Gomez-Vidal, J.A.; Litzinger, E.A.; Silverman, R.B.; Poulos, T.L. Structural Basis for Dipeptide Amide Isoform-Selective Inhibition of Neuronal Nitric Oxide Synthase. Nature Struct. Mol. Biol., 2004, 11, 54-59.
56. Gerber, N.C.; Rodriguez-Crespo, I.; Nishida, C.R.; Ortiz de Montellano, P.R. Active Site Topologies and Cofactor-Mediated Conformational Changes of Nitric-Oxide Synthases. J. Biol. Chem., 1997, 272, 6285-6290.
57. Salerno, L.; Sorrenti, V.; Di Giacomo, C.; Romeo, G.; Siracusa, M.A. Progress in the Development of Selective Nitric Oxide Synthase (NOS) Inhibitors. Curr. Pharm. Des., 2002, 8, 177-200.
58. Kerwin, J.F. Jr.; Lancaster, J.R. Jr.; Feldman, P.L. Nitric Oxide: a New Paradigm for Second Messengers. J. Med. Chem., 1995, 38, 4342-4362.
59. Li, H.; Raman, C.S.; Martásek, P.; Masters, B.S. S.; Poulos, T.L. Crystallographic Studies on Endothelial Nitric Oxide Synthase Complexed with Nitric Oxide and Mechanism-based Inhibitors. Biochemistry, 2001, 40, 5399-5406.
60. Hillier, B.J.; Christopherson, K.S.; Prehoda, K.E.; Bredt, D.S.; Lim, W.A. Unexpected Modes of PDZ Domain Scaffolding Revealed by Structure of nNOS-Syntrophin Complex. Science, 1999, 284, 812-815.
61. Nishida, C.R.; Ortiz de Montellano, P.R. Electron Transfer and Catalytic Activity of Nitric Oxide Synthases. Chimeric Constructs of the Neuronal, Inducible, and Endothelial Isoforms.J. Biol. Chem., 1998, 273, 5566-5571.
62. Siddhanta, U.; Presta, A.; Fan, B.; Wolan, D.; Rousseau, D.L.; Stuehr, D.J. Domain Swapping in Inducible Nitric-Oxide Synthase. Electron Transfer Occurs Between Flavin and Heme Groups Located on Adjacent Subunits in the Dimer.J. Biol. Chem., 1998, 273, 18950-18958.
63. Kwon, N.S.; Nathan, C.F.; Gilker, C.; Griffith, O.W.; Matthews, D.E.; Stuehr, D.J. L-Citrulline Production from L-Arginine by Macrophage Nitric Oxide Synthase. The Ureido Oxygen Derives from Dioxygen. J. Biol. Chem., 1990, 265, 13442-13445
64. Leone, A.M.; Palmer, R.M. J.; Knowles, R.G.; Francis, P.L.; Ashton, D.S.; Moncada, S. Constitutive and Inducible Nitric Oxide Synthases Incorporate Molecular Oxygen into Both Nitric Oxide and Citrulline.J. Biol. Chem., 1991, 266, 23790-23795.
65. Tayeh, M.A.; Marletta, M.A. Macrophage Oxidation of L-Arginine to Nitic Oxide, Nitrite, and Nitrate. Tetrahydrobiopterin is Required as a Cofactor.J. Biol. Chem., 1989, 264, 19654-19658.
66. Stuehr, D.J.; Kwon, N.S.; Nathan, C.F.; Griffith, O.W.; Feldman, P.L.; Wiseman, J. N-Hydroxy-Larginine is an Intermediate in the Biosynthesis of Nitric Oxide from L-Arginine.J. Biol. Chem., 1991, 266, 6259-6263.
67. Pufahl, R.A.; Nanjappan, P.G.; Woodard, R.W.; Marletta, M.A. Mechanistic Probes of N-Hydroxylation of L-Arginine by the Inducible Nitric Oxide Synthase from Murine Macrophages. Biochemistry, 1992, 31, 6822-6828.
68. Stuehr, D.J.; Griffith, O.W. Mammalian Nitric Oxide Synthases. Adv. Enzymol., 1992, 65, 287-346
69. Marletta, M.A. Nitric Oxide Synthase Structure and Mechanism.J. Biol. Chem., 1993, 268, 12231-12234.
70. Korth, H.-G.; Sustmann, R.; Thater, C.C.; Butler, A.R.; Ingold, K.U. On the Mechanism of the Nitric Oxide Synthase-Catalyzed Conversion of N-Omega-hydroxyl-L-arginine to Citrulline and Nitric Oxide.J. Biol. Chem., 1994, 269, 17776-17779
71. Kerwin, J.F. Jr.; Lancaster, J.R., Jr.; Feldman, P.L. Nitric Oxide: A New Paradigm for Second Messengers. J. Med. Chem., 1995, 38, 4343-4362
72. Pufahl, R.A.; Wishnok, J.S.; Marletta, M.A. Hydrogen Peroxide-Supported Oxidation NG-Hydroxy-L-arginine by Nitric Oxide Synthases. Biochemistry, 1995, 34, 1930-1941
73. Huang, H.; Hah, J.-M.; Silverman, R.B. Mechanism of Nitric Oxide Synthase. Evidence that Direct Hydrogen Atom Abstraction From the O-H Bond of NG-Hydroxyarginine is Not Relevant to the Mechanism. J. Am. Chem. Soc., 2001, 123, 2674-2676.
74. Olken, N.M.; Marletta, M.A. NG-Methyl-L-arginine Functions as an Alternate Substrate and Mechanism-Based Inhibitor of Nitric Oxide Synthase. Biochemistry, 1993, 32, 9677-9685.
75. Furfine, E.S.; Harmon, M.F.; Paith, J.E.; Garvey, E.P. Selective Inhibition of Constitutive Nitric Oxide Synthase by L-NG-nitroarginine. Biochemistry, 1993, 32, 8512-8517.
76. Fukuto, J.M.; Wood, K.S.; Byrns, R.E.; Ignarro, L.J. NG-Amino-L-arginine: A New Potent Antagonist of L-Arginine-Mediated Endothelium-Dependent Relaxation. Biochem. Biophys. Res. Commun., 1990, 168, 458-465.
77. Olken, N.M.; Marletta, M.A. NG-Allyl-and NG-Cyclopropyl-L-arginine: Two Novel Inhibitors of Macrophage Nitric Oxide Synthase. J. Med. Chem., 1992, 35, 1137-1144.
78. Zhang, H.Q.; Dixon, R.P.; Marletta, M.A.; Nikolic, D.; Van Breemen, R.; Silverman, R.B. Mechanism of Inactivation of Neuronal Nitric Oxide Synthase by Naa-Allyl-L-arginine. J. Am. Chem. Soc., 1997, 119, 10888-10902.
79. Lambert, L.E.; French, J.F.; Whitten, J.P.; Baron, B.M.; McDonald, I.A. Characterization of Cell Selectivity of Two Novel Inhibitors of Nitric Oxide Synthesis. Eur. J. Pharmacol., 1992, 216, 131-134.
80. Zhang, H.Q.; Fast, W.; Marletta, M.A.; Martasek, P.; Silverman, R.B. Potent and Selective Inhibition of Neuronal Nitric Oxide Synthase by N>>-Propyl-L-arginine. J. Med. Chem., 1997, 40, 3869-3870.
81. Frey, C.; Narayanan, K.; McMillan, K.; Spack, L.; Gross, S.S.; Masters, B.S.; Griffith, O.W. LThiocitrulline. A Stereospecific, Heme-Binding Inhibitor of Nitric-Oxide Synthases. J. Biol. Chem., 1994, 269, 26083-26091.
82. Bredt, D.S.; Snyder, S.H. Isolation of Nitric Oxide Synthetase, a Calmodulin-Requiring Enzyme. Proc. Natl. Acad. Sci. USA, 1990, 87, 682-685.
83. Garvey, E.P.; Tuttle, J.V.; Covington, K.; Merrill, B.M.; Wood, E.R.; Baylis, S.A.; Charles, I.G. Purification and Characterization of the Constitutive Nitric-Oxide Synthase from Human Placenta. Arch. Biochem. Biophys., 1994, 311, 235-241.
84. Pollock, J.S.; Forstermann, U.; Mitchell, J.A.; Warner, T.D.; Schmidt, H.H. H.W.; Nakane, M.; Murad, F. Purification and Characterization of Particulate Endothelium-Derived Relaxing Factor Synthase from Cultured and Native Bovine Aortic Endothelial Cells. Proc. Natl. Acad. Sci. USA, 1991, 88, 10480-10484.
85. Klatt, P.; Schmidt, K.; Brunner, F.; Mayer, B. Inhibitors of Brain Nitric Oxide Synthase. Binding Kinetics, Metabolism, and Enzyme Inactivation. J. Biol. Chem., 1994, 269, 1674-1680.
86. Feldman, P.L.; Griffith, O.W.; Hong, H.; Stuehr, D.J. Irreversible Inactivation of Macrophage and Brain Nitric Oxide Synthase by L-NG-Methylarginine Requires NADPH-Dependent Hydroxylation.J. Med. Chem., 1993, 36, 491-496.
87. Olken, N.M.; Osawa, Y.; Marletta, M.A. Characterization of the Inactivation of Nitric Oxide Synthase by NG-Methyl-L-arginine: Evidence for Heme Loss. Biochemistry, 1994, 33, 14784-14791.
88. Dwyer, M.A.; Bredt, D.S.; Snyder, S.H. Nitric Oxide Synthase: Irreversible Inhibition by L-NG-Nitroarginine in Brain in vitro and in vivo. Biochem. Biophys. Res. Commun., 1991, 176, 1136-1141.
89. Gross, S.S.; Stuehr, D.J.; Aisaka, K.; Jaffe, E.A.; Levi, R.; Griffith, O.W. Macrophage and Endothelial Cell Nitric Oxide Synthesis: Cell-Type Selective Inhibition by NG-Aminoarginine, NG-Nitroarginine, and NG-Methylarginine. Biochem. Biophys. Res. Commun., 1990, 170, 96-103.
90. Pfeiffer, S.; Leopold, E.; Schmidt, K.; Brunner, F.; Mayer, B. Inhibition of Nitric Oxide Synthase by NG-Nitro-L-arginine Methyl Ester (L-NAME): Requirement for Bioactivation to the Free Acid, NG-Nitro-Larginine. Br. J. Pharmacol., 1996, 118, 1433-1440.
91. Wolff, D.J.; Lubeskie, A. Inactivation of Nitric Oxide Synthase Isoforms by Diaminoguanidine and NG-Amino-L-arginine. Arch. Biochem. Biophys., 1996, 325, 227-234.
92. Robertson, J.G.; Bernatowicz, M.S.; Dhalla, A.M.; Muhoberac, B.B.; Yanchunas, J.; Matsueda, G.R.; Villafranca, J.J. Inhibition of Bovine Brain Nitric-Oxide Synthase by VV-Amino and---Carboxyl Derivatives of NG-Allyl-L-Arginine. Bioorg. Chem., 1995, 23, 144-151.
93. Huang, H.; Martasek, P.; Roman, L.J.; Masters, B.S. S.; Silverman, R.B. Nα-Nitroarginine-Containing Dipeptide Amides. Potent and Highly Selective Inhibitors of Neuronal Nitric Oxide Synthase. J. Med. Chem., 1999, 42, 3147-3153.
94. Babu, B.R.; Frey, C.; Griffith, O.W. L-Arginine Binding to Nitric-Oxide Synthase. The Role of H-Bonds to the Nonreactive Guanidinium Nitrogens. J. Biol. Chem., 1999, 274, 25218-25226.
95. Cooper, G.R.; Mialkowski, K.; Wolff D.J. Cellular and Enzymatic Studies of Nα-Propyl-L-arginine and S-Ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as Reversible, Slowly Dissociating Inhibitors Selective for the Neuronal Nitric Oxide Synthase Isoform. Arch. Biochem. Biophys., 2000, 375, 183-194.
96. Fedorov, R; Hartmann, E.; Ghosh, D.K.; Schlichting, I. Structural Basis for the Specificity of the Nitric Oxide Synthase Inhibitors W1400 and N_-Propyl-L-Arg for the Inducible and Neuronal Isoforms. J. Biol. Chem., 2003, 278, 45818-45825.
97. Shearer, B.G.; Lee, S.; Franzmann, K.W.; White, H.A. R.; Sanders, D.C. J.; Kiff, R.J.; Garvey, E.P.; Furfine, E.S. Conformationally Restricted Arginine Analogues as Inhibitors of Human Nitric Oxide Synthase. Bioorg. Med. Chem. Lett., 1997, 7, 1763-1768.
98. Eustache, J.; Grob, A.; Lam, C.; Seilier, O.; Schulz, G. Conformationally Constrained NO Synthase Inhibitors: Rigid Analogs of L-N-Iminoethylornithine. Bioorg. Med. Chem. Lett., 1998, 8, 2961-2966.
99. Atkinson, R.N.; Moore, L.; Tobin, J.; King, S.B. Asymmetric Synthesis of Conformationally Restricted LArginine Analogues as Active Site Probes of Nitric Oxide Synthase. J. Org. Chem., 1999, 64, 3467-3475.
100. Lee, Y.; Marletta, M.A.; Martasek, P.; Roman, L.J.; Masters, B.S. S.; Silverman, R.B. Conformationally-Restricted Arginine Analogues as Alternative Substrates and Inhibitors of Nitric Oxide Synthases. Bioorg. Med. Chem., 1999, 7, 1097-1104.
101. Fishlock, D.; Perdicakis, B.; Montgomery, H.J.; Guillemette, J.G.; Jervis, E.; Lajoie, G.A. Synthesis and Evaluation of trans-3,4-Cyclopropyl L-arginine Analogues as Isoform Selective Inhibitors of Nitric Oxide Synthase. Bioorg. Med. Chem., 2003, 11, 869-873.
102. Grant, S.K.; Green, B.G.; Stiffey-Wilusz, J.; Durette, P.L.; Shah, S.K.; Kozarich, J.W. Structural Requirements for Human Inducible Nitric Oxide Synthase Substrates and Substrate Analogue Inhibitors. Biochemistry, 1998, 37, 4174-4180.
103. Hallinan, E.A.; Tsymbalov, S.; Finnegan, P.M.; Moore, W.M.; Jerome, G.M.; Currie, M.G.; Pitzele, B.S. Acetamidine Lysine Derivative, N-(5(S)-Amino-6,7-dihydroxyheptyl)-ethanimidamide Dihydrochloride: A Highly Selective Inhibitor of Human Inducible Nitric Oxide Synthase. J. Med. Chem., 1998, 41, 775-777.
104. Ji, H.; Li, H.; Flinspach, M.; Poulos, T.L.; Silverman, R.B. Computer Modeling of Selective Regions in the Active Site of Nitric Oxide Synthases: Implication for the Design of Isoform-Selective Inhibitors. J. Med. Chem., 2003, 46, 5700-5711.
105. Silverman, R.B.; Huang, H.; Marletta, M.A.; Martásek, P. Selective Inhibition of Neuronal Nitric Oxide Synthase by N-Nitroarginine-and Phenylalanine-Containing Dipeptides and Dipeptide Esters. J. Med. Chem., 1997, 40, 2813-2817.
106. Huang, H.; Martásek, P.; Roman, L.J.; Silverman, R.B. Synthesis and Evaluation of Peptidomimetics as Selective Inhibitors and Active Site Probes of Nitric Oxide Synthases. J. Med. Chem., 2000, 43, 2938-2945.
107. Huang, H.; Martásek, P.; Roman, L.J.; Silverman, R.B. Syntheses and Evaluation of Dipeptide Amides Containing N>>-Nitroarginine and D-2,4-Diaminobutyric Acid as Inhibitors of Neuronal Nitric Oxide Synthase. J. Enzyme Inhib., 2001, 16, 233-239.
108. Gomez-Vidal, J.A.; Martásek, P.; Roman, L.J.; Silverman, R.B. Potent and Selective Conformationally Restricted Neuronal Nitric Oxide Synthase Inhibitors. J. Med. Chem., 2004, 47, 703-710.
109. Seo, J.; Martásek, P.; Roman, L.J.; Silverman, R.B. Selective L-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors. Bioorg. Med. Chem., 2007, 15, 1928-1938.
110. Ji, H.; Gómez-Vidal J.A.; Martásek, P.; Roman, L.J.; Silverman, R.B. Conformational restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors. J. Med. Chem., 2006, 49, 6254-6263.
111. Le Bourdonnec, B.; Leister, L.K.; Ajello, C.A.; Cassel, J.A.; Seida, P.R.; O'Hare, H.; Gu, M.; Chu, G.H.; Tuthill, P.A.; DeHaven, R.N.; Dolle, R.E. Discovery of a series of aminopiperidines as novel iNOS inhibitors. Bioorg. Med. Chem. Lett., 2008, 18(1), 336-343.
112. Hah, J.; Roman, L.J.; Martásek, P.; Silverman, R.B. Reduced Amide Bond Peptidomimetics. (4S)-N-(4-Amino-5-[aminoalkyl]aminopentyl)-N'-nitroguanidines, Potent and Highly Selective Inhibitors of Neuronal Nitric Oxide Synthase. J. Med. Chem., 2001, 44, 2667-2670.
113. Hah, J.; Martásek, P.; Roman, L.J.; Silverman, R.B. Aromatic Reduced Amide Bond Peptidomimetics as Selective Inhibitors of Neuronal Nitric Oxide Synthase. J. Med. Chem., 2003, 46, 1661-1669.
114. Mbadugha, B.N. A.; Seo, J.; Ji, H.; Martásek, P.; Roman, L.J.; Shea, T.M.; Li, H.; Poulos, T.L.; Silverman, R.B. Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase. Bioorg. Med. Chem., 2006, 14, 3681-3690.
115. Seo J.; Igarashi, J.; Li, H.; Martásek, P.; Roman, L.J.; Poulos, T.L.; Silverman, R.B. Structure-based design and synthesis of N>>-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water. J. Med. Chem., 2007, 50, 2089-2099.
116. Erdal, E.P.; Martásek, P.; Roman, L.J.; Silverman, R.B. Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors. Bioorg. Med. Chem, 2007, 15, 6096-6108.
117. Kobayashi, N.; Higuchi, T.; Urano, Y.; Kikuchi, K.; Hirobe, M.; Nagano, T. Dipeptides Containing LArginine Analogs: New Isozyme-Selective Inhibitors of Nitric Oxide Synthase. Biol. Pharm. Bull., 1999, 22, 936-940
118. Liu, F.-Z.; Fang, H.; Zhu, H.-W.; Wang, Q.; Yang, Y.; Xu, W.-F. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors. Bioorg. Med. Chem., 2008, 16, 578-585.
119. Park, J.M.; Higuchi, T.; Kikuchi, K.; Urano, Y.; Hori, H.; Nishino, T.; Aoki, J.; Inoue, K.; Nagano, T. Selective Inhibition of Human Inducible Nitric Oxide Synthase by S-Alkyl-L-isothiocitrulline-Containing Dipeptides. Br. J. Pharmacol., 2001, 132, 1876-1882.
120. Moore, W.M.; Webber, R.K.; Fok, K.F.; Jerome, G.M.; Kornmeier, C.M.; Tjoeng, F.S.; Currie, M.G. Inhibitors of Human Nitric Oxide Synthase Isoforms with the Carbamidine Moiety as a Common Structural Element. Bioorg. Med. Chem., 1996, 4, 1559-1564.
121. Garvey, E.P.; Oplinger, J.A.; Tanoury, G.J.; Sherman, P.A.; Fowler, M.; Marshall, S.; Harmon, M.F.; Paith, J.E.; Furfine, E.S. Potent and Selective Inhibition of Human Nitric Oxide Synthases. Inhibition by Non-Amino Acid Isothioureas. J. Biol. Chem., 1994, 269, 26669-26676.
122. Southan, G.J.; Zingarelli, B.; O'Connor, M.; Salzman, A.L.; Szabo, C. Spontaneous Rearrangement of Aminoalkylisothioureas into Mercaptoalkylguanidines, a Novel Class of Nitric Oxide Synthase Inhibitors with Selectivity Towards the Inducible Isoform. Br. J. Pharmacol., 1996, 117, 619-32.
123. Ueda, S.; Terauchi, H.; Yano, A.; Matsumoto, M.; Kubo, T.; Kyoya, Y.; Suzuki, K.; Ido, M.; Kawasaki, M. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors. Bioorg. Med. Chem., 2004, 12, 4101-4116.
124. Furfine, E.S.; Harmon, M.F.; Paith, J.; Knowles, R.G.; Salters, M.; Kiff, R.J.; Duffy, C.; Hazelwood, R.; Oplinger, J.; Garvey, E.P. Potent and Selective Inhibition of Human Nitric Oxide Synthases. Selective Inhibition of Neuronal Nitric Oxide Synthase by S-Methyl-L-thiocitrulline and S-Ethyl-L-thiocitrulline. J. Biol. Chem., 1994, 269, 26677-26683.
125. Narayanan, K.; Griffith, O.W. Synthesis of L-Thiocitrulline, L-Homothiocitrulline, and S-Methyl-Lthiocitrulline: A New Class of Potent Nitric Oxide Synthase Inhibitors. J. Med. Chem., 1994, 37, 885-887.
126. Narayanan, K.; Spack, L.; McMillan, K.; Kilbourn, R.G.; Hayward, M.A.; Masters, B.S. S.; Griffith, O.W. S-Alkyl-L-thiocitrullines. J. Biol. Chem., 1995, 270, 11103-11110.
127. Ijuin, R.; Umezawa, N.; Nagai, S.; Higuchi, T. Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes. Bioorg. Med. Chem. Lett., 2005, 15, 2881-2885.
128. Ulhaq, S.; Chinje, E.C.; Naylor, M.A.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. Heterocyclic Analogues of L-Citrulline as Inhibitors of the Isoforms of Nitric Oxide Synthase (NOS) and Identification of N>>-(4,5-Dihydrothiozol-2-yl)ornithine as a Potent Inhibitor. Bioorg. Med. Chem., 1999, 7, 1787-1796.
129. Ichimori, K.; Stuehr, D.J.; Atkinson, R.N.; King, S.B. Synthesis and Evaluation of New Sulfur-Containing L-Arginine Derived Inhibitors of Nitric Oxide Synthase. J. Med. Chem., 1992, 42, 1842-1848.
130. Babu, B.R.; Griffith, O.W. N1, N14-Bis(S-methyl)isothioureido)tetradecane: A Novel Nitric Oxide Synthase Inhibitor and Antioxidant. Portland Press Proceedings, 2000, 6 (Biology of Nitric Oxide, Part 7), 145.
131. Moore, W.M.; Webber, R.K.; Fok, K.F.; Jerome, G.M.; Connor, J.R.; Manning, P.T.; Wyatt, P.S.; Misko, T.P.; Tjoeng, F.S.; Currie, M.G. 2-Iminopiperidine and Other 2-Iminoazaheterocycles as Potent Inhibitors of Human Nitric Oxide Synthase Isoforms. J. Med. Chem., 1996, 39, 669-72.
132. Webber, R.K.; Metz, S.; Moore, W.M.; Connor, J.R.; Currie, M.G.; Fok, K.F.; Hagen, T.J.; Hansen, D.W. Jr; Jerome, G.M.; Manning, P.T.; Pitzele, B.S.; Toth, M.V.; Trivedi, M.; Zupec, M.E.; Tjoeng, F.S. Substituted 2-Iminopiperidine as Inhibitors of Human Nitric Oxide Synthase Isoforms. J. Med. Chem., 1998, 41, 96-101.
133. Naka, M.; Nanbu, T.; Kobayashi, K.; Kamanaka, Y.; Komeno, M.; Yanase, R.; Fukutomi, T.; Fujimura, S.; Seo, H.G.; Fujiwara, N.; Ohuchida, S.; Suzuki, K.; Kondo, K.; Taniguchi, N. A Potent Inhibitor of Inducible Nitric Oxide Synthase, ONO-1714, a Cyclic Amidine Derivative. Biochem. Biophys. Res. Comm., 2000, 270, 663-667.
134. Sekiguchi, F.; Mita, Y.; Kamanaka, Y.; Kawao, N.; Matsuya, H.; Taga, C.; Kawabata, A. The Potent Inducible Nitric Oxide Synthase Inhibitor ONO-1714 Inhibits Neuronal NOS and Exerts Antinociception in Rats. Neurosci. Lett., 2004, 365, 111-115.
135. Shankaran, K.; Donnelly, K.L.; Shah, S.K.; Guthikonda, R.N.; MacCoss, M.; Humes, J. L; Pacholok, S.G.; Grant, S.K. Kelly, T.M.; Wong, K.K. Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase. Bioorg. Med. Chem. Lett., 2004, 14, 4539-4544.
136. Shankaran, K.; Donnelly, K.L.; Shah, S.K.; Caldwell, C.G.; Chen, P.;. Hagmann, W.K.; MacCoss, M.; Humes, J.L.; Pacholok, S.G.; Kelly, T.M.; Grant, S.K.; Wong, K.K. Synthesis of analogs of (1,4)-3-and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases. Bioorg. Med. Chem. Lett., 2004, 14, 5907-5911.
137. McCall, T.B.; Feelisch, M.; Palmer, R.M.; Moncada, S. Identification of N-Iminoethyl-L-ornithine as an Irreversible Inhibitor of Nitric Oxide Synthase in Phagocytic Cells. Br. J. Pharmacol., 1991, 102, 234-238.
138. Babu, B.R.; Griffith, O.W. N5-(1-Imino-3-butenyl)-L-ornithine. A Neuronal Isoform Selective Mechanism-Based Inactivator of Nitric Oxide Synthase. J. Biol. Chem., 1998, 273, 8882-8889.
139. Moore, W.M.; Webber, R.K.; Jerome, G.M.; Tjoeng, F.S.; Misko, T.P.; Currie, M.G. L-N8-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase. J. Med. Chem., 1994, 37, 3886-3888.
140. Fast, W.; Nikolic, D.; Van Breemen, R.; Silverman, R.B. Mechanism of Inactivation of Inducible Nitric Oxide Synthase by N5-(1-Iminoethyl)-L-ornithine (NIO). J. Am. Chem. Soc., 1999, 121, 903-916.
141. Bretscher, L.E.; Li, H.; Poulos, T.L.; Griffith, O.W. Structural Characterization and Kinetics of Nitric-Oxide Synthase Inhibition by Novel N5-(Iminoalkyl)-and N5-(Iminoalkenyl)-ornithines. J. Biol. Chem., 2003, 278, 46789-46797.
142. Hallinan, E.A.; Tsymbalov, S.; Dorn, C.R.; Pitzele, B.S.; Hansen, Jr.D. W. Synthesis and Biological Characterization of L-N6-(1-Iminoethyl)lysine 5-Tetrazole-amide, a Prodrug of a Selective iNOS Inhibitor. J. Med. Chem., 2002, 45, 1686-1689.
143. Litzinger, E.A.; Martásek, P.; Roman, L.J.; Silverman, R.B. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors. Bioorg. Med. Chem., 2006, 14, 3185-3198.
144. Hallinan, E.A.; Kramer, S.W.; Houdek, S.C.; Moore, W.M.; Jerome, G.M.; Spangler, D.P.; Stevens, A.M.; Shieh, H.S.; Manning, P.T.; Pitzele, B.S. 4-Fluorinated L-lysine Analogs as Selective i-NOS Inhibitors: Methodology for Introducing Fluorine into the Lysine Side Chain. Org. Biomol. Chem., 2003, 1, 3527-3534.
145. Hallinan, E.A.; Hagen, T.J.; Bergmanis, A.; Moore, W.M.; Jerome, G.M.; Spangler, D.P.; Stevens, A.M.; Shieh, H.S.; Manning, P.T.; Pitzele, B.S. 5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors. J. Med. Chem., 2004, 47, 900-906.
146. Young, R.J.; Beams, R.M.; Carter, K.; Clark, H.A.R.; Coe, D.M.; Chambers, C.L.; Davies, P.I.; Dawson, J.; Drysdale, M.J.; Franzman, K.W.; French, C.; Hodgson, S.T.; Hodson, H.F.; Kleanthous, S.; Rider, P.; Sanders, D.; Sawyer, D.A.; Scott, K.J.; Shearer, B.G.; Stocker, R.; Smith, S.; Tackley, M.C.; Knowles, R.G. Inhibition of Inducible Nitric Oxide Synthase by Acetamidine Derivatives of Hetero-Substituted Lysine and Homolysine. Bioorg. Med. Chem. Lett., 2000, 10, 597-600.
147. Hallinan, E.A.; Dorn, C.R.; Moore, W.M.; Jerome, G.M.; Manning, P.T. The Synthesis of 6-Trifluoroethyl-L-Lysine: a Method to Introduce Functionality at C-6 of L-Lysine. Tetrahedron Lett., 2003, 44, 7345-7347.
148. Collins, J.L.; Shearer, B.G.; Oplinger, J.A.; Lee, S.; Garvey, E.P.; Salter, M.; Duffy, C.; Burnette, T.C.; Furfine, E.S. N-Phenylamidines as Selective Inhibitors of Human Neuronal Nitric Oxide Synthase: Structure-Activity Studies and Demonstration of in vivo Activity. J. Med. Chem., 1998, 41, 2858-2871.
149. Garvey, E.P.; Oplinger, J.A.; Furfine, E.S.; Kiff, R.J.; Laszlo, F.; Whittle, B.J.R.; Knowles, R.G. 1400W is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric Oxide Synthase in vitro and in vivo. J. Biol. Chem., 1997, 272, 4959-4963.
150. Zhu, Y.; Nikolic, D.; Van Breemen, R.B.; Silverman, R.B. Mechanism of Inactivation of Inducible Nitric Oxide Synthase by Amidines. Irreversible Enzyme Inactivation without Inactivator Modification. J. Am. Chem. Soc., 2005, 127, In press.
151. Lee, Y.; Martásek, P.; Roman, L.J.; Silverman, R.B. 1H-Pyrazole-1-carboxamidines: New Inhibitors of Nitric Oxide Synthase. Bioorg. Med. Chem. Lett., 2000, 10, 2771-2774.
152. Salerno, L.; Sorrenti, V.; Di Giacomo, C.; Romeo, G.; Siracusa, M.A. Progress in the Development of Selective Nitric Oxide Synthase (NOS) Inhibitors. Curr. Pharm. Des., 2002, 8, 177-200.
153. Zhang, Z.G.; Reif, D.; Macdonald, J.; Tang, W.X.; Kamp, D.K.; Gentile, R.J.; Shakespeare, W.C.; Murray, R.J.; Chopp, M. ARL 17477, a Potent and Selective Neuronal NOS Inhibitor Decreases Infarct Volume After Transient Middle Cerebral Artery Occlusion in Rats. J. Cereb. Blood Flow Metab., 1996, 16, 599-604.
154. Chabrier, P.; Auguet, M.; Spinnewyn, B.; Auvin, S.; Cornet, S.; Demerlé-Pallardy, C.; Guilmard-Favre C.; Marin, J.; Pignol, B.; Gillard-Roubert, V.; Roussillot-Charnet, C.; Schulz, J.; Viossat, I.; Bigg, D.; Moncada, S. BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy. Proc. Natl. Acad. Sci. USA, 1999, 96, 10824-10829.
155. Auvin, S.; Auguet, M.; Navet, E.; Harnett, J.J.; Viossat, I.; Schulz, J.; Bigg, D.; Chabrier, P.-E. Novel Inhibitors of Neuronal Nitric Oxide Synthase with Potent Antioxidant Properties. Bioorg. Med. Chem. Lett., 2003, 13, 209-212.
156. Patman, J.; Bhardwaj, N.; Ramnauth, J.; Annedi, S.C.; Renton, P; Maddaford, S.P.; Rakhit, S.; Andrews, J.S. Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 2540-2544.
157. Beaton, H.; Hamley, P.; Nicholls, D.J.; Tinker, A.C.; Wallace, A.V. 3,4-Dihydro-1-isoquinolinamines: A Novel Class of Nitric Oxide Synthase Inhibitors with a Range of Isoform Selectivity and Potency. Bioorg. Med. Chem. Lett., 2001, 11, 1023-1026.
158. Jaroch, S.; Hölscher, P.; Rehwinkel, H.; Sülzle, D.; Burton, G.; Hillmann, M.; McDonald, F.M. Dihydroquinolines as Novel n-NOS Inhibitors. Bioorg. Med. Chem. Lett., 2002, 12, 2561-2564.
159. Jaroch, S.; Hölscher, P.; Rehwinkel, H.; Sülzle, D.; Burton, G.; Hillmann, M.; McDonald, F.M. Dihydroquinolines with Amine-Containing Side Chains as Potent n-NOS Inhibitors. Bioorg. Med. Chem. Lett., 2003, 13, 1981-1984.
160. Jaroch, S.; Hölscher, P.; Rehwinkel, H.; Sülzle, D.; Burton, G.; Hillmann, M.; McDonald, F.M.; Miklautz, H. Fluorinated Dihydroquinolines as Potent n-NOS Inhibitors. Bioorg. Med. Chem. Lett., 2004, 14, 743-746.
161. Hagmann, W.K.; Caldwell, C.G.; Chen, P.; Durette, P.L.; Esser, C.K.; Lanza, T.J.; Kopka, I.E.; Guthikonda, R.; Shah, S.K.; MacCoss, M.; Chabin, R.M.; Fletcher, D.; Grant, S.K.; Green, B.G.; Humes, J.L.; Kelly, T.M.; Luell, S.; Meurer, R.; Moore, V.; Pacholok, S.G.; Pavia, T.; Williams, H.R.; Wong, K.K. Substituted 2-Aminopyridines as Inhibitors of Nitric Oxide Synthases. Bioorg. Med. Chem. Lett., 2000, 10, 1975-1978.
162. Boer, R.; Ulrich, W.R.; Klein, T.; Mirau, B.; Haas, S.; Baur, I. The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors is Solely Determined by Their Affinity Toward the Different Isoenzymes. Mol. Pharmacol., 2000, 58, 1026-1034.
163. Lowe, J.A. III.; Qian, W.; Volkmann, R.A.; Heck, S.; Nowakowski, J.; Nelson, R.; Nolan, C.; Liston, D.; Ward, K.; Zorn, S.; Johnson, C.; Vanase, M.; Faraci, W.S.; Verdries, K.A.; Baxter, J.; Doran, S.; Sanders, M.; Ashton, M.; Whittle, P.; Stefaniak, M. A New Class of Selective and Potent Inhibitors of Neuronal Nitric Oxide Synthase. Bioorg. Med. Chem. Lett., 1999, 9, 2569-2572.
164. Lowe, J.A. III.; Qian, W.; Drozda, S.E.; Volkmann, R.A.; Nason, D.; Nelson, R.B.; Nolan, C.; Liston, D.; Ward, K.; Faraci, S.; Verdries, K.; Seymour, P.; Majchrzak, M.; Villalobos, A.; White, W.F. Structure-Activity Relationships of Potent, Selective Inhibitors of Neuronal Nitric Oxide Synthase Based on the 6-Phenyl-2-aminopyridine Structure. J. Med. Chem., 2004, 47, 1575-1586.
165. Nason, D.M.; Heck, S.D.; Bodenstein, M.S.; Lowe, J.A. III.; Nelson, R.B.; Liston, D.R.; Nolan, C.E.; Lanyon, L.F.; Ward, K.M.; Volkmann, R.A. Substituted 6-Phenyl-pyridin-2-ylamines: Selective and Potent Inhibitors of Neuronal Nitric Oxide Synthase. Bioorg. Med. Chem. Lett., 2004, 14, 4511-4514.
166. Connolly, S.; Aberg, A.; Arvai, A.; Beaton, H.G.; Cheshire, D.R.; Cook, A.R.; Cooper, S.; Cox, D.; Hamley, P.; Mallinder, P.; Millichip, I.; Nicholls, D.J.; Rosenfeld, R.J.; St-Gallay, S.A.; Tainer, J.; Tinker, A.C.; Wallace, A.V. 2-Aminopyridines as Highly Selective Inducible Nitric Oxide Synthase Inhibitors. Differential Binding Modes Dependent on Nitrogen Substitution. J. Med. Chem., 2004, 47, 3320-3323.
167. Ji H.; Stanton B.Z.; Igarashi J.; Li H.; Martasek P.; Roman L.J.; Poulos T.L.; Silverman R.B. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J. Am. Chem. Soc., 2008, 130, 3900-3914.
168. Li, W.; Xue, J.; Niu, C.; Fu, H.; Lam, C.S.C.; Luo, J.; Chan, H.H.N.; Xue, H.; Kan, K.K.W.; Lee, N.T. K.; Li, C.; Pang, Y.; Li, M.; Tsim, K.W. K.; Jiang, H.; Chen, K.; Li, X.; Han, Y. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Mol. Pharmacol., 2007, 71, 1258-1267.
169. Cowart, M.; Kowaluk, E.A.; Daanen, J.F.; Kohlhaas, K.L.; Alexander, K.M.; Wagenaar, F.L.; Kerwin, Jr.J. F. Nitroaromatic Amino Acids as Inhibitors of Neuronal Nitric Oxide Synthase. J. Med. Chem., 1998, 41, 2636-2642.
170. Goodyer, C.L.M.; Chinje, E.C.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. Time-Dependence and Preliminary SAR Studies in Inhibition of Nitric Oxide Synthase Isoforms by Homologues of Thiocitrulline. Bioorg. Med. Chem. Lett., 2003, 13, 3679-3680.
171. Ueda, S.; Terauchi, H.; Kawasaki, M.; Yano, A.; Ido, M. Structure-activity relationships of 2-aminothiazole derivatives as inducible nitric oxide synthase inhibitor. Chem. Pharm. Bull., 2004, 52, 634-637.
172. Zhang, W.; Ramamoorthy, Y.; Kilicarslan, T.; Nolte, H.; Tyndale, R.F.; Sellers, E.M. Inhibition of Cytochromes P450 by Antifungal Imidazole Derivatives. Drug Metab. Dispos., 2002, 30, 314-318.
173. Hector, M.; Zhuang, Y.; Hartmann, R.W. Imidazole Substituted Biphenyls: A New Class of Highly Potent and in vivo Active Inhibitors of P450 17 as Potential Therapeutics for Treatment of Prostate Cancer. Bioorg. Med. Chem., 1999, 7, 1913-1924.
174. Murray, M. Mechanisms of the Inhibition of Cytochrome P-450-mediated Drug Oxidation by Therapeutic Agents. Drug Metab. Rev., 1987, 18, 55-81.
175. McMillan, K.; Masters, B.S. S. Optical Difference Spectroscopy as a Probe of Rat Brain Nitric Oxide Synthase Heme-Substrate Interaction. Biochemistry, 1993, 32, 9875-9880.
176. Mayer, B.; Klatt, P.; Werner, E.R.; Schmidt, K. Identification of Imidazole as L-Arg-Competitive Inhibitor of Porcine Brain Nitric Oxide Synthase. FEBS Lett., 1994, 350, 199-202.
177. Wolff, D.J.; Datto, G.A.; Samatovicz, R.A.; Tempside, R.A. Calmodulin-Dependent Nitric-Oxide Synthase: Mechanism of Inhibition by Imidazole and Phenylimidazoles. J. Biol. Chem., 1993, 168, 9425-9429.
178. Rogerson, T.D.; Wilkinson, C.F.; Hetarski, K. Steric Factors in the Inhibitory Interaction of Imidazoles with Microsomal Enzymes. Biochem. Pharmacol., 1977, 26, 1039-1042.
179. Ulhaq, S.; Chinje, E.C.; Naylor, M.A.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. S-2-Amino-5-azolylpentanoic Acids Related to L-Ornithine as Inhibitors of the Isoforms of Nitric Oxide Synthase (NOS). Bioorg. Med. Chem., 1998, 6, 2139-2149.
180. Lee, Y.; Martásek, P.; Roman, L.J.; Masters, B.S.S.; Silverman, R.B. Imidazole-Containing Amino Acids as Selective Inhibitors of Nitric Oxide Synthases. Bioorg. Med. Chem., 1999, 7, 1941-1951.
181. Wolff, D.J.; Datto, G.A.; Samatovicz, R.A. The Dual Mode of Inhibition of Calmodulin-Dependent Nitric-Oxide Synthase by Antifungal Imidazole Agents. J. Biol. Chem. 1993, 268, 9430-9436.
182. Wolff, D.J.; Gribin, B.J. Interferon-α-Inducible Murine Macrophage Nitric Oxide Synthase: Studies on the Mechanism of Inhibition by Imidazole Agent. Arch. Biochem. Biophys., 1994, 311, 293-299.
183. Handy, R.L.C.; Wallace, P.; Gaffen, Z.A.; Whitehead, K.J.; Moore, P.K. The Antinociceptive Effect of 1-(2-Trifluoromethylphenyl)imidazole (TRIM), a Potent Inhibitor of Neuronal Nitric Oxide Synthase in vitro, in the Mouse. Br. J. Pharmacol., 1995, 116, 2349-2350.
184. Handy, R.L.C.; Moore, P.K. Mechanism of the Inhibition of Neuronal Nitric Oxide Synthase by 1-(2-Trifluoromethylphenyl)imidazole (TRIM). Life Sci., 1997, 60, 389-394.
185. Volke, V.; Gregers, W.; Bourin, M.; Vasar, E. Antidepressant-and Anxiolytic-like Effects of Selective Neuronal NOS Inhibitor 1-(2-Trifluoromethylphenyl)-imidazole in Mice. Behav. Brain Res., 2003, 140, 141-147.
186. Sorrenti, V.; Di Giacomo, C.; Salerno, L.; Siracusa, M.A.; Guerrera, F.; Vanella, A. Inhibition of Neuronal Nitric Oxide Synthase by N-Phenacyl Imidazoles. Nitric Oxide, 2001, 5, 32-38.
187. Salerno, L.; Sorrenti, V.; Guerrera, F.; Sarva, M.C.; Siracusa, M.A.; DiGiacomo, C.; Vanella, A. NSubstituted-Imidazoles as Inhibitors of Nitric Oxide Synthase: a Preliminary Screening. Pharmazie, 1999, 54, 685-690.
188. Hamley, P.; Tinker, A.C. 1,2-Diaminobenzimidazoles: Selective Inhibitors of Nitric Oxide Synthase Derived from Aminoguanidine. Bioorg. Med. Chem. Lett., 1995, 5, 1573-1576.
189. Moore, P.K.; Babbedge, R.C.; Wallace, P.; Gaffen, Z.; Hart, S.L. 7-Nitroindazole, an Inhibitor of Nitric Oxide Synthase, Exhibits Anti-nociceptive Activity in the Mouse without Increasing Blood Pressure. Br. J. Pharmacol., 1993, 108, 296-297.
190. Mayer, B.; Klatt, P.; Werner, E.R.; Schmidt, K. Molecular Mechanisms of Inhibition of Porcine Brain Nitric Oxide Synthase by the Antinociceptive Drug 7-NI. Neuropharmacology, 1994, 33, 1253-1259.
191. Babbedge, R.C.; Bland-Ward, P.A.; Hart, S.L.; Moore, P.K. Inhibition of Rat Cerebellar Nitric Oxide Synthase by 7-Nitroindazole and Related Substituted Indazoles. Br. J. Pharmacol., 1993, 110, 225-228.
192. Wolff, D.J.; Gribin, B.J. The Inhibition of the Constitutive and Inducible Nitric Oxide Synthase Isoforms by Indazole Agents. Arch. Biochem. Biophys., 1994, 311, 300-306.
193. Wolff, D.J.; Lubeskie, A.; Umansky, S. The Inhibition of the Constitutive Bovine Endothelial Nitric Oxide Synthase by Imidazole and Indazole Agents. Arch. Biochem. Biophys., 1994, 314, 360-366.
194. Buchan, A.M.; Gertler, S.Z.; Huang, Z.G.; Li, H.; Chaundy, K.E.; Xue, D. Failure to Prevent Selective CA1 Neuronal Death and Reduce Cortical Infarction Following Cerebral Ischemia with Inhibition of Nitric Oxide Synthase. Neuroscience, 1994, 61, 1-11.
195. Moore, P.K.; Wallace, P.; Gaffen, Z.; Hart, S.L.; Babbedge, R.C. Characterization of the Novel Nitric Oxide Synthase Inhibitor 7-Nitroindazole and Related Indazoles: Antinociceptive and Cardiovascular Effects. Br. J. Pharmacol., 1993, 110, 219-224.
196. Ayajiki, K.; Fujioka, H.; Okamura, T.; Toda, N. Relatively Selective Neuronal Nitric Oxide Synthase Inhibition by 7-Nitroindazole in Monkey Isolated Cerebral Arteries. Eur. J. Pharmacol., 2001, 423, 179-183.
197. Huang, Z.; Huang, P.L.; Ma, J.; Meng, W.; Ayata, C.; Fishman, M.C.; Moskowitz, M.A. Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice are Attenuated by Nitro-L-Arginine. J. Cereb. Blood Flow Metab., 1996, 16, 981-987.
198. Yoshida, T.; Limmroth, V.; Irikura, K.; Moskowitz, M.A. The NOS Inhibitor, 7-Nitroindazole, Decreases Focal Infarct Volume but Not the Response to Topical Acetylcholine in Pial Vessels. J. Cereb. Blood Flow Metab., 1994, 14, 924-929.
199. Kelly, P.A. T.; Ritchie, I.M.; Arbuthnott, G.W. Inhibition of Neuronal Nitric Oxide Synthase by 7-Nitroindazole: Effects upon Local Cerebral Blood Flow and Glucose Use in the Rat. J. Cereb. Blood Flow Metab., 1995, 15, 766-773.
200. Bland-Ward, P.A.; Pitcher, A.; Wallace, P.; Gaffen, Z.; Babbedge, R.C.; Moore, P.K. Isoform Selectivity of Indazole Based Nitric Oxide Synthase Inhibitors. Br. J. Pharmacol., 1994, 112, 351p.
201. Cottyn, B.; Acher, F.; Ramassamy, B.; Alvey, L.; Lepoivre, M.; Frapart, Y.; Stuehr, D.; Mansuy, D.; Boucher, J.L.; Vichard, D. Inhibitory effects of a series of 7-substituted-indazoles toward nitric oxide synthases: Particular potency of 1H-indazole-7-carbonitrile. Bioorg Med Chem., 2008, 16, 5962-5973.
202. Wei, C.C.; Wang, Z.Q.; Arvai, A.S.; Hemann, C.; Hille, R.; Getzoff, E.D.; Stuehr, D.J. Structure of Tetrahydrobiopterin Tunes its Electron Transfer to the Heme-Dioxy Intermediate in Nitric Oxide Synthase. Biochemistry, 2003, 42, 1969-1977.
203. Hurshman, A.R.; Krebs, C.; Edmondson, D.E.; Marletta, M.A. Ability of Terahydrobiopterin Analogues to Support Catalysis by Inducible Nitric Oxide Synthase: Formation of a Pterin Radical is Required for Enzyme Activity. Biochemistry, 2003, 42, 13287-13303.
204. Werner, E.R.; Pitters, E.; Schmidt, K.; Wachter, H.; Werner-Felmayer, G.; Mayer, B. Identification of the 4-Amino Analogue of Tetrahydrobiopterin as a Dihydropteridine Reductase Inhibitor and a Potent Pteridine Antagonist of Rat Neuronal Nitric Oxide Synthase. Biochem. J., 1996, 320, 193-196.
205. Fröhlich, L.G.; Kotsonis, P.; Traub, H.; Taghavi-Moghadam, S.; Al-Masoudi, N.; Hofmann, H.; Strobel, H.; Matter, H.; Pfleiderer, W.; Schmidt, H.H.H.W. Inhibition of Neuronal Nitric Oxide Synthase by 4-Amino Pteridine Derivatives: Structure-Activity Relationship of Antagonists of (6R)-5,6,7,8-Tetrahydrobiopterin Cofactor. J. Med. Chem., 1999, 42, 4108-4121.
206. Matter, H.; Kumar, H.S.A.; Fedorov, R.; Frey, A.; Kotsonis, P.; Hartmann, E.; Fröhlich, L.G.; Reif, A.; Pfleiderer, W.; Scheurer, P.; Ghosh, D.K.; Schlichting, I.; Schmidt, H.H.H.W. Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases. J. Med. Chem., 2005, 48, 4783-4792.
207. Palumboa, A.; d'Ischiab, M.; Cioffi.F. A. 2-Thiouracil is a Selective Inhibitor of Neuronal Nitric Oxide Synthase Antagonizing Tetrahydrobiopterin-dependent Enzyme Activation and Dimerisation. FEBS Lett., 2000, 485, 109-112.
208. Giacombo, C.D.; Sorrenti, V.; Salerno, L.; Cardile, V.; Guerrera, F.; Siracusa, M.A.; Avitabile, M.; Vanella, A. Novel Inhibition of Neuronal Nitric Oxide Synthase. Exp. Biol. Med., 2003, 228, 486-490.
209. Kuroda, S.; Nakai, A.; Kristian, T.; Siesjo, B.K. The Calmodulin Antagonist Trifluoperazine in Transient Focal Brain Ischemia in Rats: Anti-ischemic Effect and Therapeutic Window. Stroke, 1997, 28, 2539-2544.
210. Sato, T.; Morishima, Y.; Sugimura, M.; Uchida, T.; Shirasaki, Y. DY-9760e, a Novel Calmodulin Antagonist, Reduces Brain Damage Induced by Transient Focal Cerebral Ischemia. Eur. J. Pharmacol., 1999, 370, 117-123.
211. Takagi, K.; Sato, T.; Shirasaki, Y.; Narita, K.; Tamura, A.; Sano, K. Post-ischemic Administration of DY-9760e, a Novel Calmodulin Antagonist, Reduced Infarct Volume in the Permanent Focal Ischemia Model of Spontaneously Hypertensive Rat. Neurol. Res., 2001, 23, 662-668.
212. Sugimura, M.; Sato, T.; Nakayama, W.; Morishima, Y.; Fukunaga, K.; Ohmitsu, M.; Miyamoto, E.; Shirasaki, Y. DY-9760e, a Novel Calmodulin Antagonist with Cytoprotective Action. Eur. J. Pharmacol., 1997, 336, 99-106.
213. Fukunaga, K.; Ohmitsu, M.; Miyamoto, E.; Sato, T.; Sugimura, M.; Uchida, T.; Shirasaki, Y. Inhibition of Neuronal Nitric Oxide Synthase Activity by 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e), a Novel Neuroprotective Agent, in vitro and in Cultured Neuroblastoma Cells in situ. Biochem. Pharmacol., 2000, 60, 693-699.
214. Hashiguchi, A.; Kawano, T.; Yano, S.; Morioka, M.; Hamada, J.; Sato, T.; Shirasaki, Y.; Ushio, Y.; Fukunaga, K. The Neuroprotective Effect of a Novel Calmodulin Antagonist, 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]-ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate, in Transient Forebrain Ischemia. Neuroscience, 2003, 121, 379-386.
215. Sato T, Morishima Y, Shirasaki Y. 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e), a Novel Calmodulin Antagonist, Reduces Brain Edema through the Inhibition of Enhanced Blood-brain Barrier Permeability after Transient Focal Focal Ischemia. J. Pharmacol. Exp. Ther., 2003, 304, 1042-1047.
216. Hashiguchi, A.; Yano, S.; Morioka, M.; Hamada, J.; Shirasaki, Y.; Kochi, M.; Fukunaga, K. The Postischemic Administration of 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e), a Novel Calmodulin Antagonist, Prevents Delayed Neuronal Death in Gerbil Hippocampus. J. Pharmacol. Sci., 2004, 96, 65-72.
217. Reiter, R.J.; Melchiorri, D.; Sewerinek, E.; Poeggeler, B.; Barlow-Walden, L.; Chuang, J.; Ortiz, G.G.; Acuna-Castroviejo, D. A Review of the Evidence Supporting Melatonin's Role as an Antioxidant. J. Pineal Res., 1995, 18, 1-11.
218. Pozo, D.; Reiter, R.J.; Calvo, J.R.; Guerrero, J.M. Physiological Concentrations of Melatonin Inhibit Nitric Oxide Synthase in Rat Cerebellum. Life Sci., 1994, 55, 455-460.
219. León, J.; Vives, F.; Crespo, E.; Camacho, E.; Espinosa, A.; Gallo, M.A.; Escames, G.; Acuña-Castroviejo, D. Modification of Nitric Oxide Synthase Activity and Neuronal Response in Rat Striatum by Melatonin and Kynurenine Derivatives. J. Neuroendocrinol., 1998, 10, 297-302.
220. León, J.; Vives, F.; Gómez, I.; Camacho, E.; Espinosa, A.; Gallo, M.A.; Escames, G.; Acuña-Castroviejo, D. Modulation of Rat Striatal Glutamatergic Response in Search for New Neuroprotective Agents: Evaluation of Melatonin and Some Kynurenine Derivatives. Brain Res. Bull., 1998, 45, 525-530.
221. León, J.; Macías, M.; Escames, G.; Camacho, E.; Khaldy, H.; Martín, M.; Espinosa, A.; Gallo, M.A.; Acuña-Castroviejo, D. Structure-related Inhibition of Calmodulin-dependent Neuronal Nitric-oxide Synthase Activity by Melatonin and Synthetic Kynurenines. Mol. Pharmacol., 2000, 58, 967-975.
222. Camacho, E.; León, J.; Carrion, A.; Entrena, A.; Escames, G.; Khaldy, H.; Acuna-Castroviejo, D.; Gallo, M.A.; Espinosa, A. Inhibition of nNOS Activity in Rat Brain by Synthetic Kynurenines: Structure-Activity Dependence. J. Med. Chem., 2002, 45, 263-274.
223. Camacho, M.E.; León, J.; Entrena, A.; Velasco, G.; Carrion, M.D.; Escames, G.; Vivo, A.; Acuna-Castroviejo, D.; Gallo, M.A.; Espinosa, A. 4,5-Dihydro-1H-pyrazole Derivatives with Inhibitory nNOS Activity in Rat Brain: Synthesis and Structure-Activity Relationships. J. Med. Chem., 2004, 45, 5641-5650.
224. Carrion, M.D.; Camacho, M.E.; Leon, J.; Escames, G.; Tapias, V.; Castroviejo, D.A.; Gallo, M.A.; Espinosa, A. Synthesis and iNOS/nNOS inhibitory activities of new benzoylpyrazoline derivatives. Tetrahedron, 2004, 60, 4051-4069.
225. Hori, H.; Iwasaki, T.; Hayashi, Y.; Kurahashi, Y.; Matsumura, T.; Nishino, T. Inhibition of Neuronal Nitric Oxide Synthase by Phosphatidylinositol 4,5-Bisphosphate and Phosphatidic Acid. J. Biochem., 1999, 126, 829-837.
226. Ohashi, K.; Kominami, S.; Yamazaki, T.; Ohta, S.; Kitamura, S. Inhibitory Effect of Organotin Compounds on Rat Neuronal Nitric Oxide Synthase through Interaction with Calmodulin. Biochem. Biophys. Res. Commun., 2004, 324, 178-185.
227. Shimazawa, R.; Sano, H.; Tanatani, A.; Miyachi, H.; Hashimoto, Y. Thalidomide as a Nitric Oxide Synthase Inhibitor and Its Structural Development. Chem. Pharm. Bull., 2004, 52, 498-499.
228. Noguchi, T.; Sano, H.; Shimazawa, R.; Tanatani, A.; Miyachi, H.; Hashimoto, Y. Phenylhomophthalimide-type NOS Inhibitors Derived from Thalidomide. Bioorg. Med. Chem. Lett., 2004, 14, 4141-4145.
229. Aoki, S.; Ye, Y.; Higuchi, K.; Takashima, A.; Tanaka, Y.; Kitagawa, I.; Kobayashi, M. Novel Neuronal Nitric Oxide Synthase (nNOS) Selective Inhibitor, Aplysinopsin-Type Indole Alkaloid, from Marine Sponge Hyrtios erecta. Chem. Pharm. Bull., 2001, 49, 1372-1374.
230. Samie, J.R.; Solomon, S.H. PIN: An Associated Protein Inhibitor of Neuronal Nitric Oxide Synthase. Science, 1996, 274, 774-777.
231. Hemmens, B.; Woschitz, S.; Pitters, E.; Klosch, B.; Volker, C.; Schmidt, K.; Mayer, B. The Protein Inhibitor of Neuronal Nitric Oxide Synthase (PIN): Characterization of Its Action on Pure Nitric Oxide Synthases. FEBS Lett., 1998, 430, 397-400.
232. Venturini, G.; Colasanti, M.; Ascenzi, P. Aprotinin, the First Competitive Protein Inhibitor of NOS Activity. Biochem. Biophys. Res. Commun., 1998, 249, 263-265.
233. Brinkworth, C.S.; Carver, J.A.; Wegener, K.L.; Doyle, J.; Llewellyn, L.E.; Bowie, J.H. The Solution Structure of Frenatin 3, a Neuronal Nitric Oxide Synthase Inhibitor from the Giant Tree Frog, Litoria infradrenata. Biopolymers, 2003, 70, 424-434.
234. Song, T; Hatano, N.; Horii, M.; Tokumitsu, H.; Yamaguchi, F.; Tokuda, M.; Watanabe, Y. Calcium/ calmodulin-dependent Protein Kinase I Inhibits Neuronal Nitric Oxide Synthase Activity Through Serine 741 Phosphorylation. FEBS Lett., 2004, 570, 133-137.
235. Colasanti, M.; Cavalieri, E.; Persichini, T.; Mollace, V.; Mariotto, S.; Suzuki, H.; Lauro, G.M. Bacterial Lipopolysaccharide plus Interferon-LLLElicit a Very Fast Inhibition of a Ca2+-dependent Nitric Oxide Synthase Activity in Human Astrocytoma Cells. J. Biol. Chem., 1997, 272, 7582-7585.
236. Colasanti, M.; Persichini, T.; Cavalieri, E.; Fabrizi, C.; Mariotto, S.; Menegazzi, M.; Lauro, G.M.; Suzuki, H. Rapid Inactivation of NOS-I by Lipopolysaccharide plus Interferon-HH-induced Tyrosine Phosphorylation. J. Biol. Chem., 1999, 274, 9915-9917.
237. Palomba, L.; Persichini, T.; Mazzone, V.; Colasanti, M.; Cantoni, O. Inhibition of Nitric-Oxide Synthase-I (NOS-I)-dependent Nitric Oxide Production by Lipopolysaccharide plus Interferon-(is Mediated by Arachidonic Acid. J. Biol. Chem., 2004, 279, 29895-29901.
238. Pukala, T.L.; Doyle, J.R.; Llewellyn, L.E.; Kuhn-Nentwig, L.; Apponyi, M.A.; Separovic, F.; Bowie, J.H. Cupiennin 1a, an antimicrobial peptide from the venom of the neotropical wandering spider Cupiennius salei, also inhibits the formation of nitric oxide by neuronal nitric oxide synthase. FEBS J., 2007, 274, 1778-1784.